Wave Life Sciences Reports Second Quarter 2024 Financial Results and Provides Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
Jones Trading Starts WAVE Life Sciences (WVE) at Buy
August 8, 2024 4:06 PM EDTJones Trading analyst Catherine Novack initiates coverage on WAVE Life Sciences (NASDAQ: WVE) with a Buy rating and a price target of $12.00.
The analyst comments "We are initiating coverage of Wave Life Sciences with a BUY rating and $12 price target. WVE's portfolio contains... More
